Donya Salmasinia Imanirad, M.D.
NPI 1063943546ActiveIndividual· Allergy & Immunology· Tampa, FL
Opted out of Medicare from April 2026 to April 2028. Allergy & Immunology (M.D.) in Tampa, Florida, licensed in FL, with an NPI issued in March 2017. Their prescriptions cost Medicare Part D more than their services did: $175,483 for 415 claims, against $10,813 paid for services in 2024. Genzyme Corporation was the largest of 10 companies reporting payments in 2025, $1,362 in all, mostly food and beverage.
Overview
| NPI | 1063943546 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | No |
| NPI issued | Mar 25, 2017 |
| Last updated in NPPES | Aug 23, 2023 |
| Certified by provider | Aug 23, 2023 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Allergy & Immunology Primary | 207K00000X | ME144904 | FL |
| Student in an Organized Health Care Education/Training Program | 390200000X | — | — |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Not in the public enrollment file of Oct 1, 2026 |
|---|---|
| Opt-out | Opted out Apr 1, 2026 – Apr 1, 2028 |
| Can order and refer | Yes |
| Accepts assignment | Yes (participating) |
During an opt-out period the provider sees Medicare patients only under private contracts, and Medicare does not pay claims for their services.
Medicare services in 2024
| Medicare patients | 28 |
|---|---|
| Services billed | 770 across 17 procedure codes |
| Paid by Medicare | $10,813 |
Part D prescriptions in 2024
| Prescriptions (claims) | 415 · 554 30-day fills |
|---|---|
| Patients | 71 |
| Total drug cost | $175,483 |
| Generic share | 74% of claims |
Industry payments (Open Payments)
- 2025$1,362 · 40 payments from 10 companies
- 2024$1,855 · 57 payments from 16 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Genzyme Corporation | $280.84 | 8 |
| Astrazeneca Pharmaceuticals LP | $234.93 | 12 |
| Regeneron Healthcare Solutions, Inc. | $207.84 | 6 |
| Glaxosmithkline, LLC. | $200.24 | 5 |
| Genentech USA, Inc. | $192.71 | 3 |
What the 2025 payments were for
- Food and Beverage$1,262 · 39 payments
- Education$99.26 · 1 payment
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other allergists in Tampa
- 1003071713
- 1093917304
- 1104850692
- 1174534473
- 1265752919
- 1295112175
- 1588829337
- 1760631741
- 1891037446
- 1942285614
- 1770518938
- 1497280168